Icon close

Close

People

Jonathan Trinh assists life sciences companies navigate complex federal, state, and FDA regulatory challenges through their products’ lifecycles.  Jonathan frequently guides companies through government and internal investigations; conducts due diligence reviews for life sciences manufacturers, private equity funds, and investment banks; and evaluates companies’ advertising and promotion practices.

Jonathan graduated from the George Washington University Law School with a concentration in health law.  There, he served as Editor-in-Chief of the Federal Circuit Bar Journal and authored a published note analyzing the ramifications of the Biologics Price Competition and Innovation Act’s “patent dance” on reference product sponsors. 

Full Bio

Credentials

J.D., George Washington University Law School

B.A. International Studies and Political Science, University of California, Berkeley, with honors

District of Columbia

Intern, Judge Rudolph Contreras, U.S. District Court for the District of Columbia

Matters

Advised Oaktree Acquisition Corp. II in its go-public merger with Alvotech Holdings SA, a transaction with a combined company value of $2.25 billion.

Icon close

Close

Matters

Advised Oaktree Acquisition Corp. II in its go-public merger with Alvotech Holdings SA, a transaction with a combined company value of $2.25 billion.

Matters

Advised Oaktree Acquisition Corp. II in its go-public merger with Alvotech Holdings SA, a transaction with a combined company value of $2.25 billion.

Icon close

Close

Matters

Advised Oaktree Acquisition Corp. II in its go-public merger with Alvotech Holdings SA, a transaction with a combined company value of $2.25 billion.

Credentials

J.D., George Washington University Law School

B.A. International Studies and Political Science, University of California, Berkeley, with honors

District of Columbia

Intern, Judge Rudolph Contreras, U.S. District Court for the District of Columbia